Skip to content

Disruption of RBPJ in liver cancer-infiltrating T cells enhances antitumor immunity through remodeling epigenetic landscape.

Aug 2026 · Cell Death and Differentiation · 0 citations · 25 references
Medicine

TL;DR

It is found that RBPJ expression rose in exhausted T cells, aggravating their exhaustion, and acarbose-induced damage in the RBPJ transcriptional complex indicated that targeting T cell exhaustion may be a promising HCC treatment.

View source

Similar papers

Open access Oct 2026

Exonuclease 1 drives immune escape in lung adenocarcinoma by regulating the HIF-1α/PD-L1 axis

Lung Adenocarcinoma (LUAD) represents the most prevalent subtype of lung cancer and additionally possesses the highest potential for lethality. EXO1 is overexpressed in multiple cancers and linked to poor prognosis, but its role in LUAD immune regulation remains unclear. Immunosuppression can be stimulated by HIF-1α, w...

Chun-Yan Gao, Lu-Lu Zhang, Bi-Wei Gao et al. · 0 citations
Open access Sep 2026

GAS5 Downregulation Promotes the Progression of Triple-Negative Breast Cancer by Regulating Tumor Cells-MDSCs Crosstalk

Background: Triple-negative breast cancer (TNBC) is exceptionally aggressive, with a high recurrence rate, resistance to chemotherapy, and a tendency to metastasize. The long non-coding RNA growth arrest-specific 5 (GAS5) is associated with TNBC progression; however, the specific mechanism still requires further explor...

Jun-Ze Du, Xin He, Ling-Feng Tang et al. · 0 citations
Open access Sep 2026

INHBB Promotes Colorectal Cancer Progression by Inducing CD8 + T Cell Exhaustion via the ACVR2B‐SMAD Signaling Axis

ABSTRACT To investigate the expression pattern, biological functions and regulatory mechanisms of inhibin beta B (INHBB) in colorectal cancer (CRC), and to clarify its role in mediating CD8+ T cell exhaustion via the INHBB‐ACVR2B‐SMAD signaling axis for identifying a novel therapeutic target in CRC targeted immunothera...

Guang-Hui Liu, Yuan-Hua Liu, Hong-Chao Zhao et al. · 0 citations
Sep 2026

The post-transcriptional regulator HuR promotes immune evasion in pancreatic ductal adenocarcinoma.

Overall, it is found that the post-transcriptional regulator HuR facilitates immune evasion in PDAC by constraining T-cell function, identifying HuR blockade as a promising therapeutic strategy in combination with immunotherapies.

Yi-Fei Guo, Jennifer M. Finan, Alexandra Q. Bartlett et al. · 0 citations
Open access Aug 2026

Kdm2a histone demethylase ablation restores anti-tumor immunogenicity in liver cancer.

KDM2A acts as a key epigenetic regulator of mitochondrial function, genomic stability, and the tumor immune microenvironment in liver cancer, and may enhance tumor immunogenicity and improve responses to immunotherapy, representing a promising therapeutic strategy.

L. Gragnani, M. Lulli, Patrizio Caini et al. · 0 citations
Open access Sep 2026

NCAPD3 induces M2 polarization of peripheral macrophages in lung adenocarcinoma by promoting the binding of E2F1 to the FOXM1 promoter region.

Serving as a highly prevalent malignant tumor, lung adenocarcinoma (LUAD) is frequently associated with the establishment of an immunosuppressive tumor microenvironment during its initiation and progression, where M2-polarized macrophages exert pivotal effects. NCAPD3 acts as an oncogenic driver in multiple tumors; how...

Wei-Xi Zhang, Kong-Jun Zou · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.